Successful treatment of hepatitis B-associated leukocytoclastic vasculitis with lamivudine treatment in a child patient

Rheumatology International

Volumn 27, Issue 9, 2007, Pages 869-872

  Surmali Onay, Ozge ^a   Baskin, Esra ^a   Ozçay, Figen ^a   Melek, Engin ^a   Canan, Oguz ^a   Bilezikçi, Banu ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Hepatitis B infection; Lamivudine; Treatment; Vasculitis

Indexed keywords

LAMIVUDINE;

ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; FAMILY HISTORY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; LABORATORY TEST; LEG EDEMA; LEUKOCYTOCLASTIC VASCULITIS; LIVER BIOPSY; MEDICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PURPURIC RASH; TREATMENT PLANNING;

ANTIVIRAL AGENTS; BLOOD VESSELS; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPATITIS B; HUMANS; LAMIVUDINE; LIVER; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME; TURKEY; VASCULITIS, HYPERSENSITIVITY;

EID: 34250204943     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0295-0     Document Type: Article

References (12)

1. Han SH (2004) Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis 8:403-418
2. Lam KC, Lai CL, Trepo C, Wu PC (1981) Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med 304:380-386
3. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI et al (1998) A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 339:61-68
4. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699
5. Pyrsopoulos NT, Reddy KR (2001). Extrahepatic manifestations of chronic viral hepatitis. Curr Gastroenterol Rep. 3:71-78
6. Fattovich G, Betterle C, Brollo L, Pedini B, Giustina G, Realdi G et al (1991) Autoantibodies during alpha-interferon therapy for chronic hepatitis B. J Med Virol 34:132-135
7. Mayet WJ, Hess G, Gerken G, Rossol S, Voth R, Manns M, Meyer zum Buschenfelde KH (1989) Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 10:24-28
8. Gregorio GV, Jones H, Choudhuri K, Vegnente A, Bortolotti F, Mieli-Vergani G, Vergani D (1996) Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa. Hepatology 24:520-523
9. Maclachlan D, Battegay M, Jacob AL, Tyndall A (2000) Successful treatment of hepatitis B-associated polyarteritis nodosa with a combination of lamivudine and conventional immunosuppressive therapy: a case report. Rheumatology (Oxford) 39:106-108
10. Filer A, Hughes A, Kane K, Mutimer D, Jobanputra P (2001) Successful treatment of hepatitis B-associated vasculitis using lamivudine as the sole therapeutic agent. Rheumatology (Oxford) 40:1064-1065
11. Stecevic V, Pevzner MM, Gordon SC (2003) Successful treatment of hepatitis B-associated vasculitis with lamivudine. J Clin Gastroenterol 36:451
12. Sawabe T, Uenotsuchi T, Imafuku S, Kohno H, Arima J, Horiuchi T (2004) Remission of hepatitis B virus-related vasculitis with lamivudine. Ann Int Med 140:672-673